UniProt ID | RFX1_HUMAN | |
---|---|---|
UniProt AC | P22670 | |
Protein Name | MHC class II regulatory factor RFX1 | |
Gene Name | RFX1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 979 | |
Subcellular Localization | Nucleus. | |
Protein Description | Regulatory factor essential for MHC class II genes expression. Binds to the X boxes of MHC class II genes. Also binds to an inverted repeat (ENH1) required for hepatitis B virus genes expression and to the most upstream element (alpha) of the RPL30 promoter.. | |
Protein Sequence | MATQAYTELQAAPPPSQPPQAPPQAQPQPPPPPPPAAPQPPQPPTAAATPQPQYVTELQSPQPQAQPPGGQKQYVTELPAVPAPSQPTGAPTPSPAPQQYIVVTVSEGAMRASETVSEASPGSTASQTGVPTQVVQQVQGTQQRLLVQTSVQAKPGHVSPLQLTNIQVPQQALPTQRLVVQSAAPGSKGGQVSLTVHGTQQVHSPPEQSPVQANSSSSKTAGAPTGTVPQQLQVHGVQQSVPVTQERSVVQATPQAPKPGPVQPLTVQGLQPVHVAQEVQQLQQVPVPHVYSSQVQYVEGGDASYTASAIRSSTYSYPETPLYTQTASTSYYEAAGTATQVSTPATSQAVASSGSMPMYVSGSQVVASSTSTGAGASNSSGGGGSGGGGGGGGGGGGGGSGSTGGGGSGAGTYVIQGGYMLGSASQSYSHTTRASPATVQWLLDNYETAEGVSLPRSTLYCHYLLHCQEQKLEPVNAASFGKLIRSVFMGLRTRRLGTRGNSKYHYYGLRIKASSPLLRLMEDQQHMAMRGQPFSQKQRLKPIQKMEGMTNGVAVGQQPSTGLSDISAQVQQYQQFLDASRSLPDFTELDLQGKVLPEGVGPGDIKAFQVLYREHCEAIVDVMVNLQFTLVETLWKTFWRYNLSQPSEAPPLAVHDEAEKRLPKAILVLLSKFEPVLQWTKHCDNVLYQGLVEILIPDVLRPIPSALTQAIRNFAKSLESWLTHAMVNIPEEMLRVKVAAAGAFAQTLRRYTSLNHLAQAARAVLQNTAQINQMLSDLNRVDFANVQEQASWVCRCEDRVVQRLEQDFKVTLQQQNSLEQWAAWLDGVVSQVLKPYQGSAGFPKAAKLFLLKWSFYSSMVIRDLTLRSAASFGSFHLIRLLYDEYMYYLIEHRVAQAKGETPIAVMGEFANLATSLNPLDPDKDEEEEEEEESEDELPQDISLAAGGESPALGPETLEPPAKLARTDARGLFVQALPSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
60 | Phosphorylation | QYVTELQSPQPQAQP CEEEECCCCCCCCCC | 37.82 | 24275569 | |
85 | Phosphorylation | LPAVPAPSQPTGAPT CCCCCCCCCCCCCCC | 51.39 | 27251275 | |
94 | Phosphorylation | PTGAPTPSPAPQQYI CCCCCCCCCCCCCEE | 35.85 | 27251275 | |
113 | Phosphorylation | SEGAMRASETVSEAS CCCCHHCCCCCHHCC | 24.36 | 25159151 | |
115 | Phosphorylation | GAMRASETVSEASPG CCHHCCCCCHHCCCC | 27.17 | 25159151 | |
117 | Phosphorylation | MRASETVSEASPGST HHCCCCCHHCCCCCC | 34.56 | 25159151 | |
120 | Phosphorylation | SETVSEASPGSTASQ CCCCHHCCCCCCHHH | 26.24 | 30278072 | |
123 | Phosphorylation | VSEASPGSTASQTGV CHHCCCCCCHHHCCC | 24.96 | 30278072 | |
124 | Phosphorylation | SEASPGSTASQTGVP HHCCCCCCHHHCCCC | 35.92 | 30278072 | |
126 | Phosphorylation | ASPGSTASQTGVPTQ CCCCCCHHHCCCCHH | 28.50 | 30278072 | |
128 | Phosphorylation | PGSTASQTGVPTQVV CCCCHHHCCCCHHHH | 37.34 | 30278072 | |
132 | Phosphorylation | ASQTGVPTQVVQQVQ HHHCCCCHHHHHHCC | 31.43 | 30108239 | |
149 | Phosphorylation | QQRLLVQTSVQAKPG CEEEEEEEEECCCCC | 24.32 | 28450419 | |
150 | O-linked_Glycosylation | QRLLVQTSVQAKPGH EEEEEEEEECCCCCC | 8.64 | 31492838 | |
150 | Phosphorylation | QRLLVQTSVQAKPGH EEEEEEEEECCCCCC | 8.64 | 22210691 | |
154 | Acetylation | VQTSVQAKPGHVSPL EEEEECCCCCCCCCC | 34.15 | 26051181 | |
159 | Phosphorylation | QAKPGHVSPLQLTNI CCCCCCCCCCCCCCC | 17.76 | 23401153 | |
164 | Phosphorylation | HVSPLQLTNIQVPQQ CCCCCCCCCCCCCCC | 19.81 | 30266825 | |
188 | Acetylation | QSAAPGSKGGQVSLT EECCCCCCCCEEEEE | 73.33 | 26051181 | |
193 | Phosphorylation | GSKGGQVSLTVHGTQ CCCCCEEEEEECCCC | 15.50 | 23401153 | |
195 | Phosphorylation | KGGQVSLTVHGTQQV CCCEEEEEECCCCEE | 11.71 | 25159151 | |
199 | Phosphorylation | VSLTVHGTQQVHSPP EEEEECCCCEECCCC | 10.84 | 25159151 | |
204 | Phosphorylation | HGTQQVHSPPEQSPV CCCCEECCCCCCCCC | 43.20 | 23401153 | |
209 | Phosphorylation | VHSPPEQSPVQANSS ECCCCCCCCCCCCCC | 25.94 | 25159151 | |
215 | Phosphorylation | QSPVQANSSSSKTAG CCCCCCCCCCCCCCC | 34.31 | 20068231 | |
216 | Phosphorylation | SPVQANSSSSKTAGA CCCCCCCCCCCCCCC | 38.14 | 20068231 | |
217 | Phosphorylation | PVQANSSSSKTAGAP CCCCCCCCCCCCCCC | 35.36 | 20068231 | |
218 | Phosphorylation | VQANSSSSKTAGAPT CCCCCCCCCCCCCCC | 35.65 | 20068231 | |
220 | Phosphorylation | ANSSSSKTAGAPTGT CCCCCCCCCCCCCCC | 32.07 | 26074081 | |
244 | O-linked_Glycosylation | VQQSVPVTQERSVVQ EECCCCCCCCCEEEE | 20.74 | 31492838 | |
253 | Phosphorylation | ERSVVQATPQAPKPG CCEEEEECCCCCCCC | 9.99 | 25159151 | |
453 | Phosphorylation | YETAEGVSLPRSTLY CCCCCCCCCCHHHHH | 43.44 | 24719451 | |
471 | Acetylation | LLHCQEQKLEPVNAA HHHCHHCCCCCCCHH | 54.81 | 26051181 | |
486 | Phosphorylation | SFGKLIRSVFMGLRT HHHHHHHHHHHHHCC | 16.83 | 22210691 | |
502 | Phosphorylation | RLGTRGNSKYHYYGL ECCCCCCCCCEEEEE | 37.10 | - | |
514 | Phosphorylation | YGLRIKASSPLLRLM EEEEEECCCHHHHHH | 27.73 | 27966365 | |
515 | Phosphorylation | GLRIKASSPLLRLME EEEEECCCHHHHHHH | 25.15 | 26699800 | |
537 | Ubiquitination | RGQPFSQKQRLKPIQ CCCCCCHHHCCCCHH | 35.87 | 29967540 | |
537 | Acetylation | RGQPFSQKQRLKPIQ CCCCCCHHHCCCCHH | 35.87 | 25953088 | |
594 | Ubiquitination | TELDLQGKVLPEGVG CEEECCCCCCCCCCC | 27.86 | 29967540 | |
660 | Ubiquitination | AVHDEAEKRLPKAIL CCCCHHHHHCCHHHH | 67.30 | 29967540 | |
660 | Acetylation | AVHDEAEKRLPKAIL CCCCHHHHHCCHHHH | 67.30 | 26051181 | |
751 | Phosphorylation | FAQTLRRYTSLNHLA HHHHHHHHHCHHHHH | 8.34 | 23312004 | |
752 | Phosphorylation | AQTLRRYTSLNHLAQ HHHHHHHHCHHHHHH | 25.56 | 23312004 | |
753 | Phosphorylation | QTLRRYTSLNHLAQA HHHHHHHCHHHHHHH | 20.45 | 23312004 | |
768 | Phosphorylation | ARAVLQNTAQINQML HHHHHHHHHHHHHHH | 13.64 | - | |
776 | Phosphorylation | AQINQMLSDLNRVDF HHHHHHHHHHCCCCC | 34.41 | - | |
868 | Phosphorylation | IRDLTLRSAASFGSF HHHHHHHHHHHCCCH | 31.16 | 28122231 | |
871 | Phosphorylation | LTLRSAASFGSFHLI HHHHHHHHCCCHHHH | 29.83 | 28122231 | |
942 | Phosphorylation | DELPQDISLAAGGES CCCCCCCHHHCCCCC | 21.90 | 26074081 | |
949 | Phosphorylation | SLAAGGESPALGPET HHHCCCCCCCCCCCC | 20.81 | 26074081 | |
956 | Phosphorylation | SPALGPETLEPPAKL CCCCCCCCCCCCHHH | 39.28 | 26074081 | |
966 | Phosphorylation | PPAKLARTDARGLFV CCHHHCCCCCCCCCC | 28.53 | 26074081 | |
978 | Phosphorylation | LFVQALPSS------ CCCEECCCC------ | 100.00 | 25159151 | |
979 | Phosphorylation | FVQALPSS------- CCEECCCC------- | 100.00 | 25159151 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RFX1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RFX1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NFIX_HUMAN | NFIX | physical | 12624117 | |
NFIB_HUMAN | NFIB | physical | 12624117 | |
NFIC_HUMAN | NFIC | physical | 12624117 | |
HDAC1_HUMAN | HDAC1 | physical | 16464847 | |
CHIP_HUMAN | STUB1 | physical | 27283392 | |
HSP7C_HUMAN | HSPA8 | physical | 27283392 | |
RFX3_HUMAN | RFX3 | physical | 27173435 | |
HDAC1_HUMAN | HDAC1 | physical | 27173435 | |
XYLT2_HUMAN | XYLT2 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120, AND MASSSPECTROMETRY. |